HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes

NCT04396626 · clinicaltrials.gov ↗
TERMINATED
Status
975
Enrollment
INDUSTRY
Sponsor class

Stopped The study was prematurely discontinued due to significant data quality issues on August 26, 2021. There were no safety concerns that led to the decision to terminate.

Conditions

Sponsor

Pfizer